Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell therapies for serious medical conditions, ...
MiniMax Group Inc. (MiniMax or the Company; HKEX: 00100), a global AI foundation model company, today announced its financial results for the year ended December 31, 2025. FY2025 Key Highlights Total ...
MiniMax Group Inc. ("MiniMax" or the "Company"; HKEX: 00100), a global AI foundation model company, today announced its financial ...
IBAC has just introduced its new-look, digitized broker certification program dubbed, “ CAIB New Edition 1.0 .” ...
PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; anzu-cel received Orphan Drug Designation from the FDA for the treatment of ...
1d
IonQ, Inc. (IONQ) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Morgan Stanley Technology, Media & Telecom Conference 2026 March 4, 2026 8:35 PM ESTCompany ParticipantsInder Singh - CFO ...
A study published this week found that Black Medicare beneficiaries with early-stage NSCLC remain significantly less likely than White beneficiaries to receive curative treatment, largely because of ...
TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM ESTCompany ParticipantsAdam Elinoff - Senior VP, CFO ...
Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...
Rigetti Computing, Inc. (Nasdaq: RGTI) ("Rigetti" or the "Company"), a pioneer in full-stack quantum-classical computing, today announced its financial ...
Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...
The Bombay High Court set aside a consolidated GST show cause notice covering five financial years, holding that Section 74 mandates year-wise assessment and limitation. The ruling clarifies that tax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results